Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro—In Vivo Correlation

Data suitable for assembling a physiologically-based pharmacokinetic (PBPK) model for nanoparticles (NPs) remain relatively scarce. Therefore, there is a trend in extrapolating the results of in vitro and in silico studies to in vivo nanoparticle hazard and risk assessment. To evaluate the reliabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubaj, Tibor, Kozics, Katarina, Sramkova, Monika, Manova, Alena, Bastús, Neus G., Moriones, Oscar H., Kohl, Yvonne, Dusinska, Maria, Runden-Pran, Elise, Puntes, Victor, Nelson, Andrew, Gabelova, Alena, Simon, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838925/
https://www.ncbi.nlm.nih.gov/pubmed/35159859
http://dx.doi.org/10.3390/nano12030511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838925/
https://www.ncbi.nlm.nih.gov/pubmed/35159859
http://dx.doi.org/10.3390/nano12030511

Ejemplares similares